AIkido Stock Analysis

AIKI -  USA Stock  

USD 0.53  0.01  1.85%

The big decline in price over the last few months for AIkido Pharma could raise concerns from stockholders as the firm it trading at a share price of 0.53 on 1,636,877 in volume. The company directors and management failed to add value to investors and positioning the firm supply of money to exploit market volatility in December. However, diversifying your holdings with AIkido Pharma or any similar stocks can still protect your portfolios during high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently 2.45. The current volatility is consistent with the ongoing market swings in December 2021 as well as with AIkido Pharma unsystematic, company-specific events.
Please continue to Trending Equities.

AIkido Stock Analysis 

 
Refresh
The AIkido Pharma stock analysis report makes it easy to digest most publicly released information about AIkido Pharma and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. AIkido Stock analysis module also helps to analyze the AIkido Pharma price relationship with some important fundamental indicators such as market cap and management efficiency.

AIkido Stock Analysis Notes

About 16.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.49. Some equities with similar Price to Book (P/B) outperform the market in the long run. AIkido Pharma recorded a loss per share of 0.07. The entity next dividend is scheduled to be issued on the 12th of May 1980. The firm had a split on the 28th of October 2019. AIkido Pharma Inc., a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. AIkido Pharma Inc. was founded in 1967 and is based in New York, New York. AIkido Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 4 people. For more info on AIkido Pharma please contact the company at 703 992 9325 or go to https://www.aikidopharma.com.

AIkido Pharma Quarterly Cost of Revenue

0.0Share

AIkido Pharma Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. AIkido Pharma's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding AIkido Pharma or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
AIkido Pharma generated a negative expected return over the last 90 days
AIkido Pharma has some characteristics of a very speculative penny stock
AIkido Pharma has a very high chance of going through financial distress in the upcoming years
AIkido Pharma was previously known as AIkido Pharma and was traded on NASDAQ Exchange under the symbol SPEX.
The company reported the previous year's revenue of 9 K. Net Loss for the year was (5.04 M) with profit before overhead, payroll, taxes, and interest of 9 K.
AIkido Pharma currently holds about 97.17 M in cash with (5 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.08, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
AIkido Pharma has a poor financial position based on the latest SEC disclosures

AIkido Pharma Upcoming and Recent Events

Earnings reports are used by AIkido Pharma to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to AIkido Pharma previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report24th of March 2022
Next Earnings Report10th of May 2022
Next Fiscal Quarter End31st of December 2021
Next Fiscal Year End24th of March 2022
Last Quarter Report30th of September 2021
Last Earning Announcement31st of December 2020

AIkido Pharma SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. AIkido Pharma prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that AIkido Pharma investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial AIkido Pharma specific information freely available to individual and institutional investors to make a timely investment decision.
9th of December 2021
Submission of Matters to a Vote of Security Holders
View
9th of November 2021
Other Events. Submission of Matters to a Vote of Security Holders
View
2nd of November 2021
Other Events. Submission of Matters to a Vote of Security Holders
View
1st of October 2021
Other Events. Submission of Matters to a Vote of Security Holders
View
13th of August 2021
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
View
19th of July 2021
Other Events
View
2nd of July 2021
Financial Statements and Exhibits. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
View
23rd of June 2021
Other Events
View

AIkido Market Capitalization

The company currently falls under 'Micro-Cap' category with current market capitalization of 50.55 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate AIkido Pharma's market, we take the total number of its shares issued and multiply it by AIkido Pharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

AIkido Profitablity

AIkido Pharma's profitability indicators refer to fundamental financial ratios that showcase AIkido Pharma's ability to generate income relative to its revenue or operating costs. If, let's say, AIkido Pharma is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, AIkido Pharma's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of AIkido Pharma's profitability requires more research than a typical breakdown of AIkido Pharma's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
Last ReportedProjected for 2022
Return on Average Assets(0.50) (0.54) 
Return on Average Equity(0.51) (0.55) 
Return on Invested Capital(0.54) (0.58) 
Return on Sales(534.49) (576.69) 

Management Efficiency

The entity has return on total asset (ROA) of (7.65) % which means that it has lost $7.65 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (7.61) %, meaning that it created substantial loss on money invested by shareholders. AIkido Pharma management efficiency ratios could be used to measure how well aikido pharma manages its routine affairs as well as how well it operates its assets and liabilities. The current Return on Average Assets is estimated to decrease to -0.54. The current Return on Average Equity is estimated to decrease to -0.55. AIkido Pharma Goodwill and Intangible Assets are most likely to decrease significantly in the upcoming years. The last year's value of Goodwill and Intangible Assets was reported at 3.22 Million. The current Asset Turnover is estimated to increase to 0.001181, while Total Assets are projected to decrease to roughly 24.1 M.
Last ReportedProjected for 2022
Book Value per Share 0.95  0.97 
Enterprise Value over EBIT(2.30) (2.48) 
Enterprise Value over EBITDA(2.76) (2.98) 
Price to Book Value 0.93  1.04 
Tangible Assets Book Value per Share 0.98  1.01 
Enterprise Value34 M36.7 M
Tangible Asset Value35.1 M37.8 M

Technical Drivers

As of the 18th of January 2022, AIkido Pharma shows the risk adjusted performance of (0.22), and Mean Deviation of 2.05. AIkido Pharma technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to collect data for nineteen technical drivers for AIkido Pharma, which can be compared to its rivals. Please confirm AIkido Pharma variance, as well as the relationship between the maximum drawdown and semi variance to decide if AIkido Pharma is priced fairly, providing market reflects its regular price of 0.53 per share. As AIkido Pharma is a penny stock we also strongly suggest to validate its total risk alpha numbers.

AIkido Pharma Price Movement Analysis

The output start index for this execution was thirty-five with a total number of output elements of twenty-six. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. AIkido Pharma middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for AIkido Pharma. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target. View also all equity analysis or get more info about bollinger bands overlap studies indicator.

AIkido Pharma Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific AIkido Pharma insiders, such as employees or executives, is commonly permitted as long as it does not rely on AIkido Pharma's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases AIkido Pharma insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

AIkido Pharma Technical and Predictive Indicators

AIkido Pharma Forecast Models

AIkido Pharma time-series forecasting models is one of many AIkido Pharma's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary AIkido Pharma's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About AIkido Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how AIkido Pharma stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling AIkido shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as AIkido Pharma. By using and applying AIkido Stock analysis, traders can create a robust methodology for identifying AIkido entry and exit points for their positions.
Last ReportedProjected for 2022
EBITDA Margin 72.49  78.22 
Gross Margin 1.15  1.18 
Profit Margin 70.93  76.53 
AIkido Pharma Inc., a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. AIkido Pharma Inc. was founded in 1967 and is based in New York, New York. AIkido Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 4 people.

Current AIkido Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. AIkido analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. AIkido analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
2.0Strong Buy1Odds
AIkido Pharma current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most AIkido analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand AIkido stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of AIkido Pharma, talking to its executives and customers, or listening to AIkido conference calls.
AIkido Analyst Advice Details

AIkido Stock Analysis Indicators

AIkido Pharma stock analysis indicators help investors evaluate how AIkido Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading AIkido Pharma shares will generate the highest return on investment. By understating and applying AIkido Pharma stock analysis, traders can identify AIkido Pharma position entry and exit signals to maximize returns.
Shares Percent Shares Out0.26%
Quick Ratio53.71
Fifty Two Week Low0.5400
Short Percent Of Float0.26%
Forward Price Earnings-6.26
Float Shares82.56M
Fifty Two Week High2.5500
Shares Short Prior Month480.04k
Average Daily Volume Last 10 Day1.74M
Average Daily Volume In Three Month2.18M
Fifty Day Average0.6988
Two Hundred Day Average0.8551
Please continue to Trending Equities. Note that the AIkido Pharma information on this page should be used as a complementary analysis to other AIkido Pharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Fund Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Complementary Tools for AIkido Stock analysis

When running AIkido Pharma price analysis, check to measure AIkido Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AIkido Pharma is operating at the current time. Most of AIkido Pharma's value examination focuses on studying past and present price action to predict the probability of AIkido Pharma's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move AIkido Pharma's price. Additionally, you may evaluate how the addition of AIkido Pharma to your portfolios can decrease your overall portfolio volatility.
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Is AIkido Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AIkido Pharma. If investors know AIkido will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AIkido Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of AIkido Pharma is measured differently than its book value, which is the value of AIkido that is recorded on the company's balance sheet. Investors also form their own opinion of AIkido Pharma's value that differs from its market value or its book value, called intrinsic value, which is AIkido Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AIkido Pharma's market value can be influenced by many factors that don't directly affect AIkido Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AIkido Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine AIkido Pharma value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AIkido Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.